Pathogenic autoantibodies in the lambert-eaton myasthenic syndrome.
Lambert-Eaton myasthenic syndrome (LEMS) is an autoimmune disorder of neuromuscular transmission in which antibodies are directed against voltage-gated calcium channels (VGCCs). We studied the action of LEMS immunoglobulin G (IgG) on cloned human VGCCs stably transfected into human embryonic kidney...
Asıl Yazarlar: | Lang, B, Pinto, A, Giovannini, F, Newsom-Davis, J, Vincent, A |
---|---|
Materyal Türü: | Journal article |
Dil: | English |
Baskı/Yayın Bilgisi: |
2003
|
Benzer Materyaller
-
Effects of intravenous immunoglobulin on muscle weakness and calcium-channel autoantibodies in the Lambert-Eaton myasthenic syndrome.
Yazar:: Bain, P, ve diğerleri
Baskı/Yayın Bilgisi: (1996) -
Autoantibodies in the Lambert-Eaton myasthenic syndrome (LEMS) and amyotrophic lateral sclerosis (ALS)
Yazar:: Lang, B
Baskı/Yayın Bilgisi: (2007) -
Autoantibodies in the Lambert-Eaton Myasthenic Syndrome (LEMS) and Amyotrophic Lateral Sclerosis (ALS)
Yazar:: Lang, B, ve diğerleri
Baskı/Yayın Bilgisi: (2013) -
Long term outcome in Lambert-Eaton myasthenic syndrome without lung cancer.
Yazar:: Maddison, P, ve diğerleri
Baskı/Yayın Bilgisi: (2001) -
Incidence of serum anti-P/O-type and anti-N-type calcium channel autoantibodies in the Lambert-Eaton myasthenic syndrome.
Yazar:: Motomura, M, ve diğerleri
Baskı/Yayın Bilgisi: (1997)